Rockwell Medical Confirms Nasdaq Capital Market Listing
Ticker: RMTI · Form: 8-K · Filed: Jan 9, 2024 · CIK: 1041024
| Field | Detail |
|---|---|
| Company | Rockwell Medical, Inc. (RMTI) |
| Form Type | 8-K |
| Filed Date | Jan 9, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: regulatory-filing, exchange-listing, corporate-governance
TL;DR
**RMTI confirms Nasdaq listing, business as usual.**
AI Summary
Rockwell Medical, Inc. filed an 8-K on January 8, 2024, to disclose that its common stock, with a par value of $0.0001, is registered on the Nasdaq Capital Market under the trading symbol RMTI. This filing, under Regulation FD Disclosure, confirms the company's current listing status and provides updated corporate information. For investors, this matters because it reaffirms the stock's continued eligibility for trading on a major exchange, which is crucial for liquidity and investor confidence.
Why It Matters
This filing confirms Rockwell Medical's continued listing on the Nasdaq Capital Market, ensuring its stock remains accessible to a broad range of investors and maintains market liquidity.
Risk Assessment
Risk Level: low — This filing is purely informational, confirming existing listing details, and does not introduce new financial or operational risks.
Analyst Insight
This filing is primarily an administrative update. Smart investors would note the confirmation of Nasdaq listing but look for more substantive operational or financial news for investment decisions.
Key Numbers
- $0.0001 — Par value per share (The stated par value of Rockwell Medical's common stock.)
Key Players & Entities
- ROCKWELL MEDICAL, INC. (company) — the registrant filing the 8-K
- Nasdaq Capital Market (company) — the exchange where Rockwell Medical's common stock is registered
- RMTI (company) — the trading symbol for Rockwell Medical's common stock
- $0.0001 (dollar_amount) — the par value of Rockwell Medical's common stock
- January 8, 2024 (date) — the date of the earliest event reported in the 8-K
Forward-Looking Statements
- Rockwell Medical, Inc. will continue to be listed on the Nasdaq Capital Market. (ROCKWELL MEDICAL, INC.) — high confidence, target: 2025-01-08
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant as specified in its charter is ROCKWELL MEDICAL, INC.
On what date was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 8, 2024.
What is the trading symbol for Rockwell Medical, Inc.'s common stock?
The trading symbol for Rockwell Medical, Inc.'s common stock is RMTI.
On which exchange is Rockwell Medical, Inc.'s common stock registered?
Rockwell Medical, Inc.'s common stock is registered on the Nasdaq Capital Market.
What is the par value of Rockwell Medical, Inc.'s common stock?
The par value of Rockwell Medical, Inc.'s common stock is $0.0001.
Filing Stats: 519 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-01-08 17:51:20
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 RMTI Nasdaq Capital Market Indicate b
Filing Documents
- rmti-20240108.htm (8-K) — 33KB
- a20240108rmtiinvestorpre.htm (EX-99.1) — 6KB
- a20240108rmtiinvestorpre001.jpg (GRAPHIC) — 137KB
- a20240108rmtiinvestorpre002.jpg (GRAPHIC) — 233KB
- a20240108rmtiinvestorpre003.jpg (GRAPHIC) — 157KB
- a20240108rmtiinvestorpre004.jpg (GRAPHIC) — 101KB
- a20240108rmtiinvestorpre005.jpg (GRAPHIC) — 113KB
- a20240108rmtiinvestorpre006.jpg (GRAPHIC) — 138KB
- a20240108rmtiinvestorpre007.jpg (GRAPHIC) — 89KB
- a20240108rmtiinvestorpre008.jpg (GRAPHIC) — 124KB
- a20240108rmtiinvestorpre009.jpg (GRAPHIC) — 160KB
- a20240108rmtiinvestorpre010.jpg (GRAPHIC) — 155KB
- a20240108rmtiinvestorpre011.jpg (GRAPHIC) — 114KB
- a20240108rmtiinvestorpre012.jpg (GRAPHIC) — 53KB
- a20240108rmtiinvestorpre013.jpg (GRAPHIC) — 136KB
- a20240108rmtiinvestorpre014.jpg (GRAPHIC) — 122KB
- a20240108rmtiinvestorpre015.jpg (GRAPHIC) — 108KB
- a20240108rmtiinvestorpre016.jpg (GRAPHIC) — 107KB
- a20240108rmtiinvestorpre017.jpg (GRAPHIC) — 140KB
- a20240108rmtiinvestorpre018.jpg (GRAPHIC) — 166KB
- 0001628280-24-000874.txt ( ) — 3404KB
- rmti-20240108.xsd (EX-101.SCH) — 2KB
- rmti-20240108_lab.xml (EX-101.LAB) — 24KB
- rmti-20240108_pre.xml (EX-101.PRE) — 12KB
- rmti-20240108_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On January 8, 2024, Rockwell Medical, Inc. made available an updated corporate presentation. A copy of the corporate presentation is furnished herewith as Exhibit 99.1 and incorporated by reference herein. In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits The following exhibit is being furnished herewith: EXHIBIT INDEX Exhibit No. Description 99.1 Rockwell Medical, Inc. Corporate Presentation, dated January 8, 2024 104 Cover Page Interactive Data File, formatted in INline XBRL and included as Exhibit 101. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ROCKWELL MEDICAL, INC. Date: January 8, 2024 By: /s/ Mark Strobeck Mark Strobeck Chief Executive Officer